In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
P AngehrnR L Then

Abstract

The in vitro activity of cefetamet, the microbiologically active metabolite of the orally administered prodrug cefetamet pivoxil, was compared with that of cephalexin, cefaclor, cefuroxime and amoxicillin. Cefetamet was highly active against Enterobacteriaceae, Neisseria spp., Vibrio spp., Haemophilus influenzae and streptococci other than enterococci. Cefetamet inhibited cefaclor-resistant species such as Proteus vulgaris, Providencia stuartii, Providencia rettgeri and Serratia marcescens. Staphylococci, Pseudomonas aeruginosa and cephalosporinase-overproducing strains of Enterobacter cloacae were resistant to cefetamet. The superior activity of cefetamet compared with older oral beta-lactam antibiotics against a large number of gram-negative pathogens correlated with enhanced stability towards beta-lactamases. In accordance with the in vitro findings, cefetamet pivoxil showed good activity in experimental infections in the mouse and rat, suggesting satisfactory bioavailability in these animals after oral administration.

References

Dec 1, 1979·Antimicrobial Agents and Chemotherapy·N MatsubaraS Mitsuhashi
Nov 1, 1987·The Journal of Antimicrobial Chemotherapy·E E StobberinghA Houben
Jul 1, 1987·Antimicrobial Agents and Chemotherapy·Y UtsuiS Mitsuhashi
Jun 1, 1986·Antimicrobial Agents and Chemotherapy·R WiseL J Piddock
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·R J Fass, V L Helsel
Oct 1, 1985·The Journal of Antimicrobial Chemotherapy·M Peeters, P Piot
Jan 1, 1985·Chemotherapy·R L Then, I Kohl
Jan 1, 1973·Advances in Microbial Physiology·M H Richmond, R B Sykes
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·T KamimuraS Kuwahara
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·S M HardingJ Ayrton
Dec 1, 1980·Antimicrobial Agents and Chemotherapy·P AngehrnR L Then
May 1, 1980·Antimicrobial Agents and Chemotherapy·C H O'CallaghanS M Harding

❮ Previous
Next ❯

Citations

Aug 21, 1992·Pharmaceutisch Weekblad. Scientific Edition·R Janknegt
Jan 1, 1992·International Journal of Antimicrobial Agents·W CullmannH Urwyler
Aug 1, 1994·International Journal of Antimicrobial Agents·A ChibanteM Kissling
Mar 1, 1992·Antimicrobial Agents and Chemotherapy·T J Fitzgerald
Jan 1, 1990·Current Medical Research and Opinion·C StathakisM Kissling
Feb 13, 2019·Aesthetic Surgery Journal·Eric Swanson
Feb 3, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S Aathithan, G L French
Jun 4, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Katarzyna PauterBogusław Buszewski
Aug 1, 1994·Journal of Chemotherapy·M R GismondoC Fassina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.